Diabetes is a serious issue because it results in additional illnesses and consequences. Regardless of whether you have Type 1 diabetes Type 2 diabetes or both, your body isn’t properly controlling your blood glucose levels.
Long-term consequences such as heart disease, stroke, diabetes neuropathy, and order failure may result from this.
Type 1 Diabetes
results, when the pancreas’s insulin-producing beta cells (b-cells) are destroyed by the body’s weak immune system, rendering the body incapable of making insulin on its own.
Type 2 Diabetes
happens due to Insulin resistance, a disease in which the body’s many organs stop responding to the insulin that the pancreas produces.
B-cell function gradually deteriorates over time to the point where the cells can no longer create enough new insulin to combat insulin resistance.
Stem cell therapy can provide relief from the symptoms of Type 1 and Type 2 diabetes for those who are affected.
Although stem cell therapy cannot treat diabetes, it has the potential to dramatically improve a patient’s quality of life by lowering diabetes-related symptoms and consequences and slowing the disease’s development.
Advancement in any one or multiple complaint-related difficulties, such as stabilization of blood sugar circumstances, decreased blood sugar situations, frequent urination, weariness, inadequate crack mending, etc., may be seen in patients receiving stem cell diabetes treatment.
Research has revealed that it is still feasible to repair the tiny blood arteries that supply the pancreas with oxygen, encourage the formation of new vessels, and maintain and restore the production and distribution of insulin by focusing on these tiny blood vessels.
Mesenchymal stem cells derived from the umbilical cord can stimulate pancreatic tissue formation and insulin-producing cell rejuvenation in stem cell therapy for diabetes.
⁰It has been demonstrated that stem cells and regenerative cells work together to repair cells, enhance blood flow, and decrease inflammation.
Additionally, it has been demonstrated here that it enhances healthy susceptible responses and returns the body to normal functioning.
Advantages of Stem Cell in Treating Diabetes
- Human leukocyte antigen (HLA) matching is not required because human umbilical cord mesenchymal stem cells (HUC- MSCs) are vulnerable system privileged and do not experience cell rejection.
- Those stem cells are chosen that have an effective anti-inflammatory effect, the ability to modulate vulnerability, and the capacity to promote rejuvenescence.
- Invariant doses of allogeneic stem cells with high cell counts are given several times over several days.
- The umbilical cord tissues contain a lot of MSCs. There is enough evidence that MSCs derived from umbilical cord tissue are more resilient than MSCs derived from other sources.
- Evidence suggests MSCs can enter the bloodstream during injury, and it has been demonstrated that they easily localize to regions of inflammation or injury.
- MSCs can exert both protective cellular and immunomodulatory effects once reaching these locations of injured tissue, which are thought to be crucial in many auto-immune diseases.
Patients and carers must comprehend that any type of diabetes cannot be cured by current treatment methods, including stem cell therapy.
However, stem cell therapy does have the potential to improve a patient’s quality of life by easing diabetes-related symptoms and problems and slowing the disease’s progression.
Every case responds to treatment differently. It could take weeks or months for the stem cells to produce noticeable results.